Your Cart
Loading

Spanish - Ecuador Priority Conditions Packet

On Sale
$19.00
$19.00
Added to cart

Price: $19


An education-only research summary, in Spanish, covering ten conditions relevant to Ecuador. They are NOT ranked: no national data on why people in Ecuador use cannabis were found. Six are the uses named in Ecuador's 2021 medical cannabis regulation (Acuerdo Ministerial 00148-2021) and four are regional conditions taken from neighboring Argentina's RACME/CONICET survey, each clearly labeled:

- Refractory epilepsy and spasticity in multiple sclerosis

- Cancer pain, chemotherapy-induced nausea and vomiting, anorexia-cachexia

- Chronic non-cancer pain

- Sleep, anxiety and depression (regional)

- Migraine (regional)


What's inside:

- What published research does and does not show for each condition, with plain evidence-strength labels

- Clinician questions to weigh for every section

- Cautions that apply to all ten: psychosis, cannabis use disorder, hyperemesis, driving, pregnancy, product contents and medicine lists

- Why these ten in Ecuador, and why the list is unranked

- Ecuadorian legal context using the official Spanish names (Código Orgánico Integral Penal Art. 220, Acuerdo Ministerial 00148-2021, ARCSA)

- Patient handoff sheets in Spanish that a clinician may copy for patients

- 67 numbered sources; every PubMed citation checked by PMID in October 2026


14-page PDF. Spanish edition, machine-assisted translation of the English original, which governs. Native-speaker review is pending. Citations and source titles remain in their original language.


En español: síntesis de la investigación sobre diez condiciones relevantes para Ecuador, sin orden por frecuencia: seis usos nombrados en el Acuerdo Ministerial 00148-2021 y cuatro condiciones regionales de la encuesta argentina de RACME/CONICET, con hojas para pacientes y el contexto legal nacional. Solo educativo: sin dosis, sin recomendaciones de productos y sin juicios sobre interacciones.


Education only. No doses, no product recommendations, no drug-interaction verdicts. Not medical or legal advice.


By Annie Romelfanger, Romelfanger Cannabis Education. romelfangercannabis.com

You will get a PDF (293KB) file